Nederland
Interactieve versie
U vindt veel meer informatie per bedrijf en veel meer bedrijven. Ook kunt u filters toepassen en exporteren naar Excel.
Bekijken
Kite Pharma EU B.V.
Hoofddorp - Noord-Holland
www.kitepharma.com
Naam
Kite Pharma EU B.V.
Website
www.kitepharma.com
Sector
Vervaardiging van farmaceutische producten (geen grondstoffen)
Werkenden
100-499 wn.
Adres
Tufsteen 1
Postcode
2132NT
Plaatsnaam
Hoofddorp
-2025 09 1 16 2 2017 2024 3 4 454 5 5483 6 844 a about accepter acces accomplish achiev activat advanc advanced adver after afwijz akkoord all alquist am analyser and antig apparat appoint are areas as ash at attack authorized axicabtag b b-cell beher benefit beter bied blod broad brow browse-ervar by cancer car carer celest cell center certain changing chimeric chuck ciloleucel clinical collect company complaint complianc condition consumer contact continue cookie cookie-instell cookiecategorieen cookies cookieverklar cultur cur cures custom custom-mad data day december designation designed develop development diagnosed different discover diversified diversity durabl each early efficacy effort email emily engineered enginer erp ervar evaluation event every expand expanded experienc explained external fda find finding first first-lin fiv focus focused follicular follow follow-up for forward friday gallia gat gebruik gedeactiveerd gen generation gilead gilead.com global grow guidelines harness head health help high high-risk hodgkin hop if immun impossibl improv inc includes increas information infus inquiries instell interest investor isolat kind kit kitekonnect.com klik klikt knop konnect kunt larg laura leadership learn legal les levy lin location long long-term longest looking lymphoma lymphomas mad manufactur marketinginspann md media medical medicin medinfo@kitepharma.com mission modalities monday mor motivat new newsrom next non non-hodgkin novel number october on onc one one-tim only onz operation opslan our own passionat patient peopl pharma phd pipelin pleas pm policy power pres privacy proces product program pt pushing re receives recent receptor regenerativ reinforc relapsed/refractory relation releases reported research reserved resources respon responses right risk s sam sciences see show singular singularly sitegebruik sitemap sitenavigatie social sped standard statement step stories story survival system t t-cell talent target tecartus technical techn
Vind meer informatie over Kite Pharma EU B.V. in de interactieve versie